Pharmacological approaches to the management of schizophrenia (Q35117122)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12720524%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

title

Pharmacological approaches to the management of schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12720524%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

David J. Castle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720524

28 December 2023

author name string

Timothy J. R. Lambert

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720524

28 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12720524%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

5 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12720524

full work available at URL

28 December 2023

https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.2003.tb05309.x

1 reference

Crossref

DOI

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

https://onlinelibrary.wiley.com/doi/full-xml/10.5694/j.1326-5377.2003.tb05309.x

28 December 2023

1 reference

Crossref

DOI

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

Medical Journal of Australia

28 December 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12720524%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12720524%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12720524%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

S57-61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12720524%20AND%20SRC:MED&resulttype=core&format=json

Psychopharmacologic treatment of schizophrenia

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

Neuroleptics and the neuroleptic-induced deficit syndrome.

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

Minimizing the non-extrapyramidal side-effects of antipsychotics

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia.

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

Good tolerability equals good results: the patient's perspective

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

Patient response and resource management: another view of clozapine treatment of schizophrenia

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

The effects of clozapine on cognitive functioning in schizophrenia

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

Olanzapine-associated diabetes mellitus

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

Effects of newer antipsychotics on extrapyramidal function

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

Treatment of negative symptoms in schizophrenia with amisulpride

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials.

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

Switching antipsychotic therapies

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

Second-generation antipsychotics in the emergency care setting. A prospective naturalistic study

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

Zuclopenthixol acetate in the treatment of acute schizophrenia and similar serious mental illnesses

28 December 2023

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05309.X

28 December 2023

Identifiers

DOI

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12720524%20AND%20SRC:MED&resulttype=core&format=json